Raviranjan Pandey

About

My research focuses on the interface between Metallobiology and translational research, with a primary focus on developing next-generation therapeutics for Wilson disease. My scientific interests span metabolic disorders, ageing, redox-regulated disease processes, cell death, and survival strategies, in which dysregulated metal homeostasis and redox imbalance converge to drive pathology. I aim to uncover mechanistic links between metal trafficking, cellular stress responses, and disease progression, and to translate these insights into innovative therapeutic platforms using chemical biology tools.
I bring strong interdisciplinary expertise spanning molecular biology and chemical biology, with advanced technical proficiency in CRISPR–Cas9 genome editing, high-resolution microscopy, and in vivo disease models, including zebrafish and C. elegans.
I am actively seeking postdoctoral opportunities in leading research environments to expand my research interest at the interface of fundamental biology and clinical translation.

Employment

• Indian Institute of Science Education and Research Kolkata SRF
  2020 - 2025

Education

• Indian Institute of Science Education and Research Kolkata PhD
  2020 - 2025
• Cooch Behar Panchanan Barma University M.Sc
  2017 - 2019
• North Bengal St. Xavier’s College B.Sc
  2014 - 2017

Projects & Funding

Projects & funding information is unavailable.

Publications (10)

• A dual-function guanidinium scaffold for copper sequestration and redox protection in Wilson disease models
  Free Radical Biology and Medicine 2026 DOI: 10.1016/j.freeradbiomed.2026.08.015
  +Save
• Balancing copper: From redox biology to disease and therapy
  Redox Biochemistry and Chemistry 2026 DOI: 10.1016/j.rbc.2026.100085
  +Save
• Sequence‐Defined Short Peptide‐Derived Coacervate Vesicles for Targeted Therapeutics
  Advanced Materials 2026 DOI: 10.1002/adma.73804
  +Save
• Copper-transporting ATPase ATP7B and the lysosomal exocytosis pathway synergise to detoxify cadmium from cells
  BioRxiv 2026 DOI: 10.64898/2026.05.16.725294
  +Save
• Reductive microenvironment-activated paclitaxel-BODIPY nanoassemblies for self-reporting drug delivery
  Organic & Biomolecular Chemistry 2026 DOI: 10.1039/D6OB00954A
  +Save
• Repurposing melatonin's therapeutic potential in Wilson disease: Addressing copper overload and redox imbalance
  REDOX BIOLOGY 2026 DOI: 10.1016/J.REDOX.2025.103971
  +Save
• Repurposing Melatonin in dual-mode for Wilson disease therapy as a Copper Chelator and an antioxidant agent
  BioRxiv 2025 DOI: 10.1101/2025.08.30.673002
  +Save
• Leishmania major-induced alteration of host cellular and systemic copper homeostasis drives the fate of infection
  Communications Biology 2024 DOI: 10.1038/s42003-024-06716-2
  +Save
• Microtubule-Targeting NAP Peptide-Ru(II)-polypyridyl Conjugate As a Bimodal Therapeutic Agent for Triple Negative Breast Carcinoma
  JOURNAL OF THE AMERICAN CHEMICAL SOCIETY 2024 DOI: 10.1021/JACS.4C11820
  +Save
• Copper-independent lysosomal localisation of the Wilson disease protein ATP7B
  TRAFFIC 2023 DOI: 10.1111/TRA.12919
  +Save